Clearer Healthtech Ltd

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—5

Registered number: 13726549

		31 December 2024		30 November 2023
	Notes	£	£	£	£
FIXED ASSETS
Intangible Assets	4		63,702		-
Tangible Assets	5		2,758		-

			66,460		-
CURRENT ASSETS
Stock	6	14,045		13,037
Debtors	7	2,932		3,081
Cash at bank and in hand		12,766		2,377

		29,743		18,495
Creditors: Amounts Falling Due Within One Year	8	(55,920 )		(4,455 )

NET CURRENT ASSETS (LIABILITIES)			(26,177 )		14,040

TOTAL ASSETS LESS CURRENT LIABILITIES			40,283		14,040

Creditors: Amounts Falling Due After More Than One Year	9		(243,782 )		(49,980 )

NET LIABILITIES			(203,499 )		(35,940 )

CAPITAL AND RESERVES
Called up share capital	10		1		1
Profit and Loss Account			(203,500 )		(35,941 )

SHAREHOLDERS' FUNDS			(203,499)		(35,940)

Page 1

Page 2

Clearer Healthtech Ltd

Balance Sheet (continued)

As At 31 December 2024

For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Ka Wa Wong

Director

25/09/2025

The notes on pages 3 to 5 form part of these financial statements.

1. General Information

Clearer Healthtech Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13726549 . The registered office is Chancery Station House, 31-33 High Holborn, London, WC1V 6AX.

The financial year end of the Company has changed from 30 November to 31 December. Therefore, the current financial statements have been prepared for 13 months from 01 December 2023 to 31 December 2024.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

2.3. Intangible Fixed Assets and Amortisation - Other Intangible

The Company's intangible asset is a software application which is being developed internally. The cost of software is capitalised based on the development costs incurred. The estimated useful life will be determined by considering factors such as the expected lifespan of the technology and the ongoing maintenance requirements. Amortisation will begin once the software application is available for its intended use.

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Computer Equipment

25% straight line method

2.5. Stocks and Work in Progress

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

2.6. Foreign Currencies

Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.

2.7. Taxation

Income tax expense represents the sum of the tax currently payable.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Current tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current tax is also recognised in other comprehensive income or directly in equity respectively.

3. Average Number of Employees

Average number of employees, including directors, during the period was: 1 (2023: 1)

Page 3

Page 4

Clearer Healthtech Ltd

Notes to the Financial Statements (continued)

For the Period 1 December 2023 to 31 December 2024

4. Intangible Assets

	Other
	£
Cost
As at 1 December 2023	-
Additions	63,702

As at 31 December 2024	63,702

Net Book Value
As at 31 December 2024	63,702

As at 1 December 2023	-

5. Tangible Assets

	Computer Equipment
	£
Cost
As at 1 December 2023	-
Additions	3,164

As at 31 December 2024	3,164

Depreciation
As at 1 December 2023	-
Provided during the period	406

As at 31 December 2024	406

Net Book Value
As at 31 December 2024	2,758

As at 1 December 2023	-

6. Stock

	31 December 2024	30 November 2023
	£	£
Stock	14,045	13,037

7. Debtors

	31 December 2024	30 November 2023
	£	£
Due within one year
Trade debtors	-	1,092
VAT	2,932	1,989

	2,932	3,081

Page 4

Page 5

Clearer Healthtech Ltd

Notes to the Financial Statements (continued)

For the Period 1 December 2023 to 31 December 2024

8. Creditors: Amounts Falling Due Within One Year

	31 December 2024	30 November 2023
	£	£
Trade creditors	19,048	1,475
Other loans	32,662	-
Accruals and deferred income	4,210	2,980

	55,920	4,455

9. Creditors: Amounts Falling Due After More Than One Year

	31 December 2024	30 November 2023
	£	£
Directors loan account	243,782	49,980

10. Share Capital

	31 December 2024	30 November 2023
	£	£
Allotted, Called up and fully paid	1	1

Page 5